This is part of the "Advancing the Science of Cancer in Latinos: 2022 Conference Proceedings," which summarizes findings and discussions of the 2022 Advancing the Science of Cancer in Latinos Conference on Feb. 23-25, 2022, in San Antonio, Texas.
Using Science to Address Latino Health Disparities Research
Eliseo J. Pérez-Stable, M.D., is Director of the National Institute on Minority Health and Health Disparities (NIMHD) at the National Institutes of Health (NIH). Health disparities and social determinants of health Dr. Pérez-Stable began his presentation by discussing the ways in which science can reduce inequities in healthcare. First, standardized surveys, tools, and measurements are needed so that data can be combined, facilitating discovery through large data sets. ...
This is part of the "Advancing the Science of Cancer in Latinos: 2022 Conference Proceedings," which summarizes findings and discussions of the 2022 Advancing the Science of Cancer in Latinos Conference on Feb. 23-25, 2022, in San Antonio, Texas.
Transformative Strategies for Integration of Health Equity Principles in Science and Access in the US
Dr. Edith A. Perez is the Serene M. and Frances C. Durling Professor of Medicine at the Mayo Clinic College of Medicine and the Chief Medical Officer at Bolt Biotherapeutics. Her presentation outlined strategies for health equity as exemplified by the National Academies of Sciences, Engineering, and Medicine (NASEM) Committee for Inclusion in Research, and the Health Equity Committee at Stand Up To Cancer (SU2C). The NASEM initiative, ...
This is part of the "Advancing the Science of Cancer in Latinos: 2022 Conference Proceedings," which summarizes findings and discussions of the 2022 Advancing the Science of Cancer in Latinos Conference on Feb. 23-25, 2022, in San Antonio, Texas.
Updates in Genomics of Breast Cancer among Latina Women
Dr. Elad Ziv is a Professor of Medicine at the University of California San Francisco (UCSF), with a research focus on human genetics of cancer susceptibility and hematological traits. Genomics explained To set the stage for his presentation, Dr. Ziv explained genomics in a lay-friendly way, describing it as a long series of letters. A change of one letter in this series, from an A to a G for example, can lead to anything from a change in height to a disease susceptibility. Not ...
This is part of the "Advancing the Science of Cancer in Latinos: 2022 Conference Proceedings," which summarizes findings and discussions of the 2022 Advancing the Science of Cancer in Latinos Conference on Feb. 23-25, 2022, in San Antonio, Texas.
Addressing Systemic Inequities and Structural Racism to Advance Health Equity for Latinos
Dr. Marcella Nunez-Smith is an internal medicine physician, the Associate Dean for Health Equity Research at Yale School of Medicine, and the Associate Director for Community Outreach and Engagement at the Cancer Center. Dr. Nunez-Smith served as chair of the Presidential COVID-19 Health Equity Task Force, and is one of the nation's foremost experts on disparities in healthcare access. Health Disparities Affecting Marginalized Communities Dr. ...
This is part of the "Advancing the Science of Cancer in Latinos: 2022 Conference Proceedings," which summarizes findings and discussions of the 2022 Advancing the Science of Cancer in Latinos Conference on Feb. 23-25, 2022, in San Antonio, Texas.
Healthcare inequity in the Latinx community
The United States healthcare system is rife with systemic inequities affecting the Latinx community, the largest ethnic minority in the country with a population of 60.6 million [Estrada]. Health disparities include higher rates of infant mortality, stroke, cancer, heart disease, diabetes, hypertension, and COVID-19, and are often rooted in systemic racism and unconscious bias. [Webb Hooper, Duma] Latinx patients, especially those who are uncomfortable discussing care in English, are often stereotyped ...
Consuming cold-water fish and other sources of omega-3 fatty acids could preserve brain health and enhance cognition in middle age, according to a recent study led by researchers at UT Health San Antonio and the Framingham Heart Study. “Our results, albeit exploratory, suggest that higher omega-3 fatty acid concentrations are related to better brain structure and cognitive function in a predominantly middle-aged cohort free of clinical dementia,” according to the study.
What Are Omega-3s?
Omega-3s are a family of essential fatty acids that play an important role in the human body. “Although evidence is mixed, studies indicate that omega-3 fatty acids can protect against all sorts of illnesses, including breast cancer, depression, ADHD, and various inflammatory diseases,” ...
The National Institutes of Health's UNITE initiative has responded to over 1,100 comments, including one from Dr. Amelie Ramirez of Salud America! and UT Health San Antonio, calling for racial equity and diversity in research. UNITE sought comments in spring 2021. Ramirez submitted a comment—endorsed by 541 Salud America! members—that we believe that increasing diversity among research leaders and clinical trial participants will help achieve true health equity, especially for Latinos and others disproportionately impacted by health issues. Based on these comments, the UNITE initiative formulated four priority areas in health disparities and minority health research, the internal NIH workforce, and the external research workforce. "Here at NIH, we saw with fresh eyes the ...
U.S. Latinos face heavier burdens of stomach, liver, and cervical cancers, and worse outcomes for many cancers, than their White peers. But why? Unfortunately, many factors cause these disparities, from poverty and a lack of healthcare access to cultural barriers, acculturation, and genetic heritage. That's why it takes everyone working together to address Latino cancer. To this end, UT Health San Antonio has published a new open-access book, Advancing the Science of Cancer in Latinos: Building Collaboration for Action. The book is a collection of articles based on presentations at the 2nd biennial Advancing the Science of Cancer in Latinos conference on Feb. 26-28, 2020, in San Antonio, co-hosted by Mays Cancer Center and the Institute for Health Promotion Research (IHPR) ...
Rapamycin is a medication approved by the US Food and Drug Administration as an immunosuppressant drug, making it helpful in preventing rejection in organ transplantation. The medication has also been tested in prior studies — like clinical trials, which help researchers learn how to better slow, manage, and treat diseases — as a treatment for cancer and to evaluate its effects on physical and cognitive function and immune health. Now, researchers at UT Health San Antonio are recruiting participants for a study to evaluate Rapamycin’s effects on heart function, heart muscle stiffening, and circulation. Participants will be compensated up to $300 for study completion, which involves five study visits over the course of about two months.
Who Can Participate in the Rapamycin ...
